Sort
39,280 grants matching “leukemia”
Inflammation resolution, neuroprotection, and brain repair to promote stroke recovery
$414,035Jun Chen · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · NS
Ikaros regulation: study on hemo-lymphopoiesis
$414,024Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2017 · HL
Ikaros regulation: study on hemo-lymphopoiesis
$414,024Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2018 · HL
Ikaros regulation: study on hemo-lymphopoiesis
$414,024Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2019 · HL
Ikaros regulation: study on hemo-lymphopoiesis
$414,024Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2020 · HL
Incorporating FLT3 Inhibitors into AML Treatment Regimens
$414,005Mark J Levis · University Of Tx Md Anderson Can Ctr · P50 · FY2009 · CA
Mechanisms of inv(16) acute myeloid leukemia
$413,998Lucio H. Castilla · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · CA
Development of a novel imaging modality for adoptive cell therapy
$413,974David Wald · Case Western Reserve University · R21 · FY2021 · CA
Investigating a Novel Inhibitory Receptor in Regulating CAR-T Cell Persistence and Function
$413,971Li Lily Wang · Cleveland Clinic Lerner Com-Cwru · R21 · FY2024 · CA
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment
$413,948Steven David Mittelman · Children'S Hospital Of Los Angeles · R01 · FY2016 · CA
TET2-mediated transcriptional and epigenetic control of normal and malignant hematopoiesis
$413,948Mingjiang Xu · University Of Texas Hlth Science Center · R01 · FY2022 · HL
Epigenomic Changes in Normal T-cell Development and Leukemogenesis
$413,948Richard A Young · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy
$413,943Stanley R Riddell · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Cancer and Leukemia Group B
$413,820Harold J. Burstein · Dana-Farber Cancer Inst · U10 · FY2009 · CA
Functional Genomic Dissection of Refractory Anemia
$413,800Benjamin Levine Ebert · Brigham And Women'S Hospital · R01 · FY2010 · HL
BRAIN NEOPLASMS, LEUKEMIA &PETROCHEMAL EXPOSURES
$413,798Harvard University (Sch Of Public Hlth) · R01 · FY2002 · ES
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD
$413,768George F Murphy · Brigham And Women'S Hospital · R01 · FY2023 · HL
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD
$413,768George F Murphy · Brigham And Women'S Hospital · R01 · FY2025 · HL
The role of the SF3B1 splicing factor in chronic lymphocytic leukemia
$413,759Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2013 · HL
Southern Oncology Network on Adverse Reactions (SONAR) - Focus on Tyrosine Kinase
$413,755Richard Michael Schulz · University Of South Carolina At Columbia · R01 · FY2013 · CA
MKL in megakaryocytopoiesis
$413,750Diane S. Krause · Yale University · R01 · FY2010 · DK
Endothelial lineage specification and differentiation in vertebrate embryos
$413,750Suk-Won Jin · Yale University · R01 · FY2012 · HL
Role of Tissue Antigen Presenting Cells in GVHD
$413,750Warren D Shlomchik · Yale University · R01 · FY2011 · HL
Fate of Spermatogonial Stem Cells
$413,748Martin Dym · Georgetown University · R01 · FY2006 · HD
Genetic Basis of Myeloid Neoplasia--Mutagenesis Screens
$413,683Dana-Farber Cancer Institute · R01 · FY2002 · CA